SK278441B6 - Ether of 1-benzyl-3-hydroxymethylindazole with aliphatic 2-hydroxy acids, preparation method and intermediate product thereof, pharmaceutical composition containing same and application - Google Patents

Ether of 1-benzyl-3-hydroxymethylindazole with aliphatic 2-hydroxy acids, preparation method and intermediate product thereof, pharmaceutical composition containing same and application Download PDF

Info

Publication number
SK278441B6
SK278441B6 SK563-90A SK56390A SK278441B6 SK 278441 B6 SK278441 B6 SK 278441B6 SK 56390 A SK56390 A SK 56390A SK 278441 B6 SK278441 B6 SK 278441B6
Authority
SK
Slovakia
Prior art keywords
formula
compound
benzyl
group
ether
Prior art date
Application number
SK563-90A
Other languages
English (en)
Slovak (sk)
Other versions
SK56390A3 (en
Inventor
Leandro Baiocchi
Bruno Silvestrini
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of SK56390A3 publication Critical patent/SK56390A3/sk
Publication of SK278441B6 publication Critical patent/SK278441B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SK563-90A 1989-02-07 1990-02-06 Ether of 1-benzyl-3-hydroxymethylindazole with aliphatic 2-hydroxy acids, preparation method and intermediate product thereof, pharmaceutical composition containing same and application SK278441B6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947620A IT1230441B (it) 1989-02-07 1989-02-07 Eteri della serie dell'indazolo

Publications (2)

Publication Number Publication Date
SK56390A3 SK56390A3 (en) 1997-05-07
SK278441B6 true SK278441B6 (en) 1997-05-07

Family

ID=11261479

Family Applications (1)

Application Number Title Priority Date Filing Date
SK563-90A SK278441B6 (en) 1989-02-07 1990-02-06 Ether of 1-benzyl-3-hydroxymethylindazole with aliphatic 2-hydroxy acids, preparation method and intermediate product thereof, pharmaceutical composition containing same and application

Country Status (36)

Country Link
US (2) US4999367A (ro)
EP (1) EP0382276B1 (ro)
JP (1) JP2870925B2 (ro)
KR (1) KR0145525B1 (ro)
CN (2) CN1046505C (ro)
AR (1) AR247386A1 (ro)
AT (1) ATE127115T1 (ro)
AU (1) AU624895B2 (ro)
BG (1) BG50273A3 (ro)
CA (1) CA2009503C (ro)
CZ (1) CZ280121B6 (ro)
DD (2) DD291995A5 (ro)
DE (2) DE69021902T2 (ro)
DK (1) DK0382276T3 (ro)
EG (1) EG19170A (ro)
ES (1) ES2020171T3 (ro)
FI (1) FI102678B (ro)
GE (1) GEP19971030B (ro)
GR (2) GR910300073T1 (ro)
HU (1) HU204793B (ro)
IL (1) IL93132A (ro)
IN (1) IN170957B (ro)
IT (1) IT1230441B (ro)
LT (1) LT3604B (ro)
LV (1) LV10612B (ro)
NZ (1) NZ232258A (ro)
PE (1) PE25091A1 (ro)
PH (1) PH26552A (ro)
PL (2) PL163720B1 (ro)
PT (1) PT93067B (ro)
RO (1) RO106252B1 (ro)
RU (3) RU2066318C1 (ro)
SK (1) SK278441B6 (ro)
UA (1) UA26852C2 (ro)
YU (1) YU47943B (ro)
ZA (1) ZA90644B (ro)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
US5943270A (en) * 1997-11-26 1999-08-24 Intel Corporation Two-transistor DRAM cell for logic process technology
US7514463B2 (en) 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
AR070813A1 (es) 2008-03-07 2010-05-05 Acraf Nuevos derivados de 1- bencil -3-hidroximetilindazol y su utilizacion en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1
LT2262778T (lt) 2008-03-07 2019-11-11 Acraf 1-benzil-3-hidroksimetilindazolo dariniai ir jų panaudojimas gydant ligas, pagrįstas mcp-1, cxcr1 ir p40 raiška
EP2254869B1 (en) * 2008-03-07 2017-05-31 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Neue 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of cx3cr1 und p40
CA2765461C (en) 2009-08-03 2017-04-11 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.S.P.A. Process for the preparation of 1-benzyl-3-hydr0xymethyl-1h-indaz0le and its derivatives and required magnesium intermediates
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
CA3095012C (en) 2012-05-01 2023-02-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
WO2013171316A1 (en) 2012-05-18 2013-11-21 Sanofi Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation
RU2645344C2 (ru) 2012-05-18 2018-02-21 Санофи Производные пиразола и их применение в качестве lpar5 антагонистов
CN108047136B (zh) * 2017-12-20 2021-07-09 长春普华制药股份有限公司 一种苄达酸的精制方法
EP3990433A4 (en) * 2019-06-25 2023-07-26 Translatum Medicus Inc. METHODS FOR THE MANUFACTURE OF 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES
CN113929627A (zh) * 2021-10-19 2022-01-14 吕梁学院 一种宾达利的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3470298A (en) * 1969-01-29 1969-09-30 Acraf Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
IT1131779B (it) 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1189052B (it) 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
IT1194564B (it) 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
IT1197805B (it) 1986-08-01 1988-12-06 Acraf Metodo per il tratamento di lenti a contatto

Also Published As

Publication number Publication date
AU4906690A (en) 1990-08-16
ZA90644B (en) 1991-01-30
CN1034016C (zh) 1997-02-12
DE382276T1 (de) 1991-11-28
RU2066318C1 (ru) 1996-09-10
DD295363A5 (de) 1991-10-31
DE69021902T2 (de) 1996-05-23
EP0382276B1 (en) 1995-08-30
HUT53088A (en) 1990-09-28
GR3018165T3 (en) 1996-02-29
YU20690A (sh) 1992-07-20
DE69021902D1 (de) 1995-10-05
LV10612B (en) 1995-08-20
AU624895B2 (en) 1992-06-25
US5112986A (en) 1992-05-12
JP2870925B2 (ja) 1999-03-17
PE25091A1 (es) 1991-08-17
UA26852C2 (uk) 1999-12-29
PT93067B (pt) 1995-12-29
IN170957B (ro) 1992-06-20
YU47943B (sh) 1996-07-24
IT8947620A0 (it) 1989-02-07
LV10612A (lv) 1995-04-20
CN1046505C (zh) 1999-11-17
RO106252B1 (ro) 1993-03-31
HU204793B (en) 1992-02-28
IL93132A (en) 1994-05-30
FI102678B1 (fi) 1999-01-29
GEP19971030B (en) 1997-06-13
SK56390A3 (en) 1997-05-07
ES2020171T3 (es) 1995-12-01
EG19170A (en) 1994-11-30
EP0382276A3 (en) 1990-12-12
GR910300073T1 (en) 1991-11-15
PT93067A (pt) 1990-08-31
PL163730B1 (pl) 1994-04-29
JPH02240065A (ja) 1990-09-25
BG50273A3 (en) 1992-06-15
FI102678B (fi) 1999-01-29
ATE127115T1 (de) 1995-09-15
CA2009503A1 (en) 1990-08-07
DK0382276T3 (da) 1996-01-15
LT3604B (en) 1995-12-27
KR0145525B1 (ko) 1998-08-17
CA2009503C (en) 2000-04-11
US4999367A (en) 1991-03-12
CZ56390A3 (en) 1995-06-14
HU900689D0 (en) 1990-04-28
PH26552A (en) 1992-08-19
RU2055071C1 (ru) 1996-02-27
DD291995A5 (de) 1991-07-18
CN1044810A (zh) 1990-08-22
ES2020171A4 (es) 1991-08-01
IL93132A0 (en) 1990-11-05
LTIP872A (en) 1995-03-27
CN1088201A (zh) 1994-06-22
IT1230441B (it) 1991-10-23
NZ232258A (en) 1991-06-25
CZ280121B6 (cs) 1995-11-15
KR900012913A (ko) 1990-09-03
EP0382276A2 (en) 1990-08-16
RU2044729C1 (ru) 1995-09-27
AR247386A1 (es) 1994-12-29
PL163720B1 (pl) 1994-04-29
FI900577A0 (fi) 1990-02-06

Similar Documents

Publication Publication Date Title
SK278441B6 (en) Ether of 1-benzyl-3-hydroxymethylindazole with aliphatic 2-hydroxy acids, preparation method and intermediate product thereof, pharmaceutical composition containing same and application
Sugiura et al. Syntheses and antiinflammatory and hypnotic activity of 5-alkoxy-3-(N-substituted carbamoyl)-1-phenylpyrazoles. 4
EP0851855B9 (fr) Derives acyles de la melatonine et d'analogues en tant que medicament
US20060142387A1 (en) Chemical compounds
EP0172096A1 (fr) Dérivés d'acylaminométhyl-3 imidazo[1,2-a]pyridines, leur préparation et leur application en thérapeutique
NO162615B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4,5-tetrahydrobenz (c,d) indoler.
KR20010040550A (ko) 벤조티아디아졸 및 유도체
ES2381180T3 (es) Utilización de derivados de indol como activadores de nurr-1, para el tratamiento de la enfermedad de parkinson
SU1156593A3 (ru) Способ получени производных бензамида или их кислотно-аддитивных солей,или оптических изомеров
US20040034011A1 (en) Derivatives of naphthalene with comt inhibiting activity
EP0021857B1 (fr) Dérivés de l'indole, leur préparation et medicaments les contenant
EP1047664B1 (fr) Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PL195667B1 (pl) Nowe związki cykliczne zawierające łańcuch cyklopropylenowy, sposób ich wytwarzania, kompozycje farmaceutyczne zawierające te związki i ich zastosowanie
FI61879C (fi) Analogifoerfarande foer framstaellning av nya terapeutiskt effektiva aminopyrrolderivat
EP0579129B1 (en) Thiadiazole derivatives for the treatment of depressive states
FR2697520A1 (fr) Dérivés de benz[e]indende.
Clarke et al. A series of hexahydro [1, 4] oxazino [3, 4-a] isoquinolines as potential neuroleptics
Freed et al. Antidepressants. 1 II. Derivatives of Polynuclear Indoles
US20040147585A1 (en) Method for the synthesis of Soritin compounds
FR2955110A1 (fr) Nouveaux derives de type pyrrolopyridine benzoique
PT89981B (pt) Processo para a preparacao de quinolina-2,5-dionas e de composicoes farmaceuticas que as contem
FR2606411A1 (fr) Imidazopyridine-acetamides, leur preparation et leur application en therapeutique
SI9010206A (sl) Etri 1-benzil-3-hidroksimetil-indazola z alifatskimi 2-hidroksi kislinami
FR2646850A1 (fr) Derives d'acide dibenzo(b,e)thiepinne-3-acetique, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20100206